Study Assessing AR-1105 in Subjects With Macular Edema Due to Retinal Vein Occlusion (RVO)

NCT03739593 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

49

Enrollment

INDUSTRY

Sponsor class

Conditions

Macular Edema

Interventions

DRUG: AR-1105-CF1
DRUG: AR-1105-CF2

Sponsor

Aerie Pharmaceuticals